Join
Live feed
·
PRReleasevia Quantisnow
Upstream Bio Inc. logo

Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma

ByQuantisnow·Wall Street's wire, on your screen.
UPB· Upstream Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UPB (Upstream Bio Inc.) and more on Quantisnow.